22157.jpg
Global $19.7 Bn Gastroretentive Drug Delivery Systems Markets to 2028 Featuring F. Hoffmann La Roche, Ranbaxy, GlaxoSmithKline, & Depomed
September 28, 2021 05:53 ET | Research and Markets
Dublin, Sept. 28, 2021 (GLOBE NEWSWIRE) -- The "Global Gastroretentive Drug Delivery Systems Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global gastroretentive...
22157.jpg
Global Oral Proteins & Peptides Market Research Report (2021 to 2026) - by Drug Type and Region
September 10, 2021 07:53 ET | Research and Markets
Dublin, Sept. 10, 2021 (GLOBE NEWSWIRE) -- The "Oral Proteins & Peptides Market Research Report by Drug Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been...
lexaria.jpg
Lexaria Bioscience Corp. (NASDAQ: LEXX) on Forefront of Exciting Hypertension Innovation
August 06, 2021 08:30 ET | Lexaria Bioscience Corp.
NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Cardiovascular Disease Drug Market Offers...
lexaria.jpg
Lexaria Bioscience Corp. (NASDAQ: LEXX) Leads the Way in Innovating Hypertension Treatment
August 04, 2021 08:30 ET | Lexaria Bioscience Corp.
NEW YORK, Aug. 04, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+...
Attachment.jpg
Mountain Valley MD Appoints Chief Medical Officer
August 03, 2021 08:45 ET | Mountain Valley MD Holdings Inc.
TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (FRA:20MP) (OTCQB: MVMDF) is pleased to announce the appointment of Dr. Azhar Rana...
ibn-iw-globe-2.png
InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast Featuring Mark Palumbo, Founder & CEO of CannAssist International Corp.
February 17, 2021 08:17 ET | InvestorBrandNetwork (IBN)
LOS ANGELES, Feb. 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
lexaria.jpg
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Featured in NetworkNewsAudio Publication Discussing Innovative Drug-Delivery Discovery
September 06, 2019 08:30 ET | Lexaria Bioscience Corp.
NEW YORK, Sept. 06, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) announces the availability of a NetworkNewsAudio publication titled, “Innovative...
lexaria.jpg
Lexaria Bioscience Corp. Featured in CannabisNewsWire Publication Discussing Disruptive Potential of CBD Delivery Technology
May 30, 2019 08:35 ET | Lexaria Bioscience Corp.
NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsWire – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announces its placement in an editorial published by CannabisNewsWire...
Receptor Holdings Adds Alex Casdin to Board of Directors
April 08, 2019 08:50 ET | Receptor Holding
SEATTLE, April 08, 2019 (GLOBE NEWSWIRE) -- Alexander W. Casdin, Founder, CEO, and Portfolio Manager of Reneo Capital Management LP, has been named to the Board of Directors of Receptor Holdings...
Plandai Biotechnology Exploring Opportunities in the U.S. Poultry Market
July 03, 2018 08:00 ET | Plandai Biotechnology, Inc.
SORBEO™ Proprietary PREMIX Addresses Needs in the $65 Billion Industry LONDON, UNITED KINGDOM , July 03, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or...